The pharmaceutical unit dose packaging market is predicted to expand from a current value of US$34.2 billion in 2023 to US$136 billion in 2033, at a compound annual growth rate (CAGR) of 14.8%.
The market for pharmaceutical unit dose packaging is expanding as product traceability and safety take on more significance. Growing public awareness of the dangers of drug tampering and contamination has increased the demand for packaging options that can shield drugs from these dangers. The legitimacy and safety of medications are enhanced by the use of technology like e-pedigree systems, which track and trace the movement of drugs across the supply chain.
Another factor influencing the expansion of blister-based unit dose packaging is the availability of active pharmaceutical ingredients (APIs). Market expansion has been aided by the availability of APIs and improvements in production and development facilities.
For More Insights on this Market, Get A Sample Report @https://www.futuremarketinsights.com/reports/sample/rep-gb-5236
Unit dose packaging is in greater demand as a result of the rising demand for elder and child-resistant packaging. These packaging choices enhance patient safety and lower the possibility of medication errors by preventing children and senior citizens from accidentally ingesting medications. Additionally, the market's rising income is influenced by the rising consumption of prescription medications.
The global spending on medicine is increasing, particularly in developed countries where healthcare diagnostics and overall standards, including medicine, are improving. This adoption of improved healthcare practices is expected to drive market growth.
The rise in drug consumption rates and the evolution of e-commerce platforms also contribute to the growing demand for pharmaceutical unit dose packaging. E-commerce platforms simplify drug access and ensure compliance with strict regulations for safe logistics
Overall, the pharmaceutical unit dose packaging market is driven by factors such as the need for product traceability and safety, the supply of APIs, demand for child-resistant and senior-friendly packaging, global spending on medicine, increased drug consumption rates, and the evolution of e-commerce platforms. These factors create significant growth opportunities for the market.
Key Takeaways
- North America is expected to dominate the industry by accumulating over 38.6 % revenue share by end of the forecast period.
- The market in India is projected to witness the fastest CAGR of 7.90% during the forecast period.
- China is projected to exhibit a 6.90 % of CAGR in Pharmaceutical Unit Dose Packaging market.
- By packaging type, vials are projected to account for 35% market share by end of the forecast period.
- By material type, Plastic is expected to lead the market by withholding 47.9 % of revenue share in 2023.
“A surge in demand for over-the-counter drugs will especially create a favorable ground for pharmaceutical packaging materials. In addition, increasing preference for single-dose packaging formats, and rapid expansion of e-Pharmacy will further propel growth in the market”- comments an FMI Analyst
Ask an Analyst: https://www.futuremarketinsights.com/ask-question/rep-gb-5236
Competitive Landscape
The Pharmaceutical Unit Dose Packaging market is extremely competitive and consists of numerous key industry players. These players are innovating new products in the respiratory devices domain. This is expected to propel the pharmaceutical unit dose packaging market. The key industry players are:
Gerresheimer AG, West Pharmaceuticals Services, Inc, Schott AG, SGD SA, Stevanato Group S.p.a., Klockner Pentaplast Group, UDG Healthcare plc., Nipro Corporation, Amcor plc., Adelphi Healthcare Packaging, Winpak Ltd., Berry Global, Inc., Comar LLC, Constantia Flexibles Group GmbH, Catalent Inc., Becton, Dickinson and Company, Pacific Vial Manufacturing Inc., Sonoco Products Company, WestRock Company, AptarGroup, Inc.
Key market players are leveraging on inorganic growth strategies like acquisition, mergers, partnerships, and collaboration in order to enhance their product portfolio. This is expected to fuel the global Pharmaceutical Unit Dose Packaging Market.
- In May 2021, ‘Gerresheimer’ showcased a new platform for on body infusion pump “SensAIR” that can deliver drugs of high viscosity. It is simple to use and helps in the self-determination of medication.
- In January 2022, ‘Berry Global Group’ and ‘Raw Elements USA’ collaborated to introduce a sugarcane-based sustainable tube. The tubes are manufactured from waste sugarcane, which is converted into high-density polyethylene and low-density polyethylene to make a material with the same chemical composition as polyethylene obtained from fossil fuels.
- In June 2021, Amcor PLC introduced the ‘ACT2100’ heat seal coating for use with medical-grade DuPont Tyvek2 and paper packaging. This innovative coating process enhances the performance characteristics of medical applications.
More Valuable Insights Available
Future Market Insights offers an unbiased analysis of the global pharmaceutical unit dose packaging market, providing historical data for 2018 to 2022 and forecast statistics from 2023 to 2033.
To understand opportunities in the pharmaceutical unit dose packaging market, the market is segmented on the basis of product, material, end-use, and regions.
Want your report customized? Speak to an analyst and personalize your report according to your needs: https://www.futuremarketinsights.com/customization-available/rep-gb-5236
Key Segments Profiled in the Pharmaceutical Unit Dose Packaging Industry Survey
By Product:
- Blisters
- Ampoules
- Vials
- Prefilled Syringes & Cartridges
By Material:
- Plastic
- Polyethylene
- Polypropylene
- Polyvinyl Chloride
- Polyethylene Terephthalate
- Aluminium
- Glass
- Paper & Paperboard
By End Use:
- Ophthalmic
- Injectable
- Biologics
- Wound Care
- Respiratory Therapy
- Orals
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
